Journal profile · Virology

AIDS

ISSN 0269-9370 · eISSN 1473-5571 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Semimonthly · Founded 1987

AIDS: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 2.88; JCR Q2 (journal website); hybrid open access; median 96 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 50%; 344 articles in 2025; indexed in SCIE and Scopus.

Impact factor2.88Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 3 · Medicine
Review time96 daysMedian, submission to acceptance · 97 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptanceabout 50%Community average
Articles per year3442025 · OpenAlex count

Scope

Aims, scope and focus

AIDS is published by Lippincott Williams and Wilkins Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are HIV Research and Treatment, HIV/AIDS Research and Interventions and HIV/AIDS drug development and treatment, together about 53.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

Source: LetPub

Research area (LetPub): Virology

Editor-in-chief Michael S. SaagPublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. HIV Research and TreatmentImmunology and Microbiology20.8%
  2. HIV/AIDS Research and InterventionsMedicine18.8%
  3. HIV/AIDS drug development and treatmentMedicine13.9%
  4. HIV-related health complications and treatmentsMedicine11.4%
  5. Adolescent Sexual and Reproductive HealthHealth Professions4.2%
  6. HIV, Drug Use, Sexual RiskMedicine3.9%
  7. Pneumocystis jirovecii pneumonia detection and treatmentMedicine3.8%
  8. Hepatitis C virus researchMedicine2.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorVirologyZone 2
MinorImmunologyZone 3
MinorInfectious DiseasesZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorImmunologyZone 3
MinorInfectious DiseasesZone 3
MinorVirologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorImmunologyZone 2
MinorInfectious DiseasesZone 2
MinorVirologyZone 2

Top journal: noReview journal: no

JCR / CiteScore quartiles on the journal's website

Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.88LetPub ·
Impact factor (publisher)
2.9Publisher website ·
CiteScore 2026-06
4.8LetPub ·
SJR 2026-06
1.14LetPub ·
SNIP 2026-06
0.92LetPub ·
h-index
203LetPub ·
h-index
269OpenAlex ·
i10-index
10,482OpenAlex ·
2-year mean citedness
2.05OpenAlex ·
Self-citation rate
6.9%LetPub ·
Share of gold OA articles
24.79%LetPub ·

Volume

Articles per year
253LetPub ·

Articles by year OpenAlex count · 16,069 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261868037
2025344193562
20242801661,059
20233742192,203
20223172093,356
20213542315,124

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

96 daysMedian, submission to acceptance · P25–P75 58 days – 135 days

Acceptance to online
median 28 days (97 articles)
Submission to online
median 133 days
Sample
97 articles with submission and acceptance dates (606 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 1 monthLetPub ·
Average acceptance (community reports)
50%LetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Lippincott Williams and Wilkins Ltd.
Country or region
UNITED STATES
Language
English
Frequency
Semimonthly
Founded
1987
ISSN
0269-9370
Electronic ISSN
1473-5571
Latest issue on the website
Volume 40, Issue 10 (October 2026)
Official links

FAQ

Frequently asked questions about AIDS

What CAS zone is AIDS in?

In the 2025 upgraded edition of the CAS Journal Ranking, AIDS is in Zone 2 of Medicine, and in Zone 2 of the minor category Virology / Immunology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of AIDS?

The latest impact factor listed by LetPub is 2.88; CiteScore 4.8, h-index 269.

How long does peer review take at AIDS?

Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 58–135 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What JCR quartile is AIDS in?

The journal's website gives JCR Q2; by category, IMMUNOLOGY Q3 (116/183), INFECTIOUS DISEASES Q2 (64/141), VIROLOGY Q2 (22/44). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.

Which databases index AIDS?

According to LetPub and DOAJ records, AIDS is indexed in SCIE and Scopus.

Is AIDS open access, and what is the APC?

AIDS is a hybrid journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .